These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30430397)

  • 21. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
    Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
    Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells.
    Li X; Li X; Wang J; Ye Z; Li JC
    Int J Biol Sci; 2012; 8(6):901-12. PubMed ID: 22745580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
    Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models.
    D'Amato V; Rosa R; D'Amato C; Formisano L; Marciano R; Nappi L; Raimondo L; Di Mauro C; Servetto A; Fusciello C; Veneziani BM; De Placido S; Bianco R
    Br J Cancer; 2014 Jun; 110(12):2887-95. PubMed ID: 24823695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
    Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
    BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
    Liu RX; Ma Y; Hu XL; Ren WY; Liao YP; Wang H; Zhu JH; Wu K; He BC; Sun WJ
    Int J Oncol; 2018 Nov; 53(5):2091-2101. PubMed ID: 30132514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deprivation of asparagine triggers cytoprotective autophagy in laryngeal squamous cell carcinoma.
    Ji Y; Li L; Tao Q; Zhang X; Luan J; Zhao S; Liu H; Ju D
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4951-4961. PubMed ID: 28352997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH; Pi J; Jin H; Cai JY
    J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
    Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galangin suppresses human laryngeal carcinoma via modulation of caspase-3 and AKT signaling pathways.
    Wang HX; Tang C
    Oncol Rep; 2017 Aug; 38(2):703-714. PubMed ID: 28677816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
    Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
    Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X; Liu F; Li M
    Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glaucocalyxin A induces apoptosis and autophagy in tongue squamous cell carcinoma cells by regulating ROS.
    Shi F; Xue D; Jiang Q; Qiu J
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):235-246. PubMed ID: 33904969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of G(2)/M phase arrest and apoptosis by oridonin in human laryngeal carcinoma cells.
    Kang N; Zhang JH; Qiu F; Chen S; Tashiro S; Onodera S; Ikejima T
    J Nat Prod; 2010 Jun; 73(6):1058-63. PubMed ID: 20496901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells.
    Cheng Y; Qiu F; Ye YC; Guo ZM; Tashiro S; Onodera S; Ikejima T
    FEBS J; 2009 Mar; 276(5):1291-306. PubMed ID: 19187231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
    Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin AR; Rossi M; Patel M; El-Deiry M; Wadsworth JT; Chen Z; Khuri FR; Shin DM; Saba NF; Chen ZG
    Clin Cancer Res; 2017 Feb; 23(3):677-686. PubMed ID: 27358485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1.
    Zeng R; Chen Y; Zhao S; Cui GH
    Acta Pharmacol Sin; 2012 Jan; 33(1):91-100. PubMed ID: 22158107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
    Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
    Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab.
    Yamazaki M; Yamashita Y; Kubo N; Yashiro M; Ohira M; Ako E; Tanaka H; Muguruma K; Sawada T; Hirakawa K
    Oncol Rep; 2012 Jul; 28(1):49-54. PubMed ID: 22562413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK.
    Ren CM; Li Y; Chen QZ; Zeng YH; Shao Y; Wu QX; Yuan SX; Yang JQ; Yu Y; Wu K; He BC; Sun WJ
    Oncol Rep; 2016 May; 35(5):2691-8. PubMed ID: 26986967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.